ArticleProtoplasma2026
Glutamine synthetase GLN1;5 and ACT domain repeat ACR1 functionally interact at the seed level in Arabidopsis thaliana.
Article in Protoplasma, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
GLN1;5 is one of the five Arabidopsis thaliana glutamine synthetase (GS) cytosolic isoenzymes, almost exclusively expressed in seeds, where it plays a critical role in nitrogen reassimilation during seed maturation and germination. ACT Domain Repeat (ACR) proteins are believed to act as nutrient sensors, although their precise functions in plants remain unclear. The eFP browser expression analysis shown that one ACR isogene, AtACR1, entirely overlaps with AtGLN1;5 expression, suggesting a possible interaction between these proteins. This study aimed to elucidate the functional relationship between the two proteins, using an integrated approach combining phenotypic, biochemical, and molecular analyses. The similarity in phenotypes of the two mutants, acr1 and gln1;5 highlights the crucial role of both proteins in nutrient utilization during germination and supports their potential interaction. Furthermore, in acr1 seeds, GS activity was reduced despite increased protein levels and gene expression, especially of the GLN1;5. Pull-down assays using recombinant proteins and seed extracts from wild-type, acr1, and gln1;5 mutants confirmed a specific interaction between ACR1 and GLN1;5. In addition, recombinant ACR1 protein enhances GS activity in wild-type but not in gln1;5 mutant seed extracts, indicating a regulatory role of ACR1 in GLN1;5 activation. Hormonal treatment of wild-type seed revealed antagonistic regulation of ACR1 and GLN1;5 genes by abscisic and gibberellic acid during germination, further supporting a role for ACR1 in modulating GS activity during this process. By using complementary and alternative approaches, our findings establish ACR1 as a key regulator of glutamine synthetase in seeds, with implications for normal seedling development.
Indexed as
Identifiers
42786292What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.